These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 33613279)

  • 21. Clinical Features and Risk Factors for Drug-Induced Liver Injury: A Retrospective Study From China.
    Ma X; Chen Z; An J; Zhang C
    Clin Ther; 2024 May; ():. PubMed ID: 38821767
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drug-Induced Liver Injury in Latin America: 10-year experience of the Latin American DILI (LATINDILI) Network Drug-induced liver injury in Latin America.
    Bessone F; Hernandez N; Medina-Caliz I; García-Cortés M; Schinoni MI; Mendizabal M; Chiodi D; Nunes V; Ridruejo E; Pazos X; Santos G; Fassio E; Parana R; Reggiardo V; Tanno H; Sanchez A; Tanno F; Montes P; Tagle M; Arrese M; Brahm J; Girala M; Lizarzabal MI; Carrera E; Zerega A; Bianchi C; Reyes L; Arnedillo D; Cordone A; Gualano G; Jaureguizahar F; Rifrani G; Robles-Díaz M; Ortega-Alonso A; Pinazo-Bandera JM; Stephens C; Sanabria-Cabrera J; Bonilla-Toyos E; Niu H; Alvarez-Alvarez I; Lucena MI; Andrade RJ
    Clin Gastroenterol Hepatol; 2024 Jul; ():. PubMed ID: 38992407
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An Update on Drug-induced Liver Injury.
    Devarbhavi H
    J Clin Exp Hepatol; 2012 Sep; 2(3):247-59. PubMed ID: 25755441
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Drug-Induced Liver Injury during Consolidation Therapy in Childhood Acute Lymphoblastic Leukemia as Assessed for Causality Using the Updated RUCAM.
    Qin FL; Sang GY; Zou XQ; Cheng DH
    Can J Gastroenterol Hepatol; 2022; 2022():5914593. PubMed ID: 35369115
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Causality assessment in drug-induced liver injury using a structured expert opinion process: comparison to the Roussel-Uclaf causality assessment method.
    Rockey DC; Seeff LB; Rochon J; Freston J; Chalasani N; Bonacini M; Fontana RJ; Hayashi PH;
    Hepatology; 2010 Jun; 51(6):2117-26. PubMed ID: 20512999
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Herb-induced liver injury (HILI) with 12,068 worldwide cases published with causality assessments by Roussel Uclaf Causality Assessment Method (RUCAM): an overview.
    Teschke R; Eickhoff A; Schulze J; Danan G
    Transl Gastroenterol Hepatol; 2021; 6():51. PubMed ID: 34423172
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Worldwide Use of RUCAM for Causality Assessment in 81,856 Idiosyncratic DILI and 14,029 HILI Cases Published 1993-Mid 2020: A Comprehensive Analysis.
    Teschke R; Danan G
    Medicines (Basel); 2020 Sep; 7(10):. PubMed ID: 33003400
    [No Abstract]   [Full Text] [Related]  

  • 28. [Clinical and pathological features in 138 cases of drug-induced liver injury].
    Lai RT; Wang H; Gui HL; Ye MZ; Dai WJ; Xiang XG; Zhao GD; Wang WJ; Xie Q
    Zhonghua Gan Zang Bing Za Zhi; 2012 Mar; 20(3):185-9. PubMed ID: 22475136
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A case report of a drug-induced liver injury (DILI) caused by multiple antidepressants with causality established by the updated Roussel Uclaf causality assessment method (RUCAM) and in vitro testing.
    González-Muñoz M; Monserrat Villatoro J; Marín-Serrano E; Stewart S; Bardón Rivera B; Marín J; Martínez de Soto L; Seco Meseguer E; Ramírez E
    Clin Case Rep; 2020 Dec; 8(12):3105-3109. PubMed ID: 33363890
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Significant Medical Comorbidities Are Associated With Lower Causality Scores in Patients Presenting With Suspected Drug-Induced Liver Injury.
    Ghabril M; Gu J; Yoder L; Corbito L; Dakhoul L; Ringel A; Beyer CD; Vuppalanchi R; Barnhart H; Hayashi PH; Chalasani N
    Clin Transl Gastroenterol; 2020 Apr; 11(4):e00141. PubMed ID: 32251016
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular Idiosyncratic Toxicology of Drugs in the Human Liver Compared with Animals: Basic Considerations.
    Teschke R
    Int J Mol Sci; 2023 Apr; 24(7):. PubMed ID: 37047633
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of pharmacist active consultation on clinical outcomes and quality of medical care in drug-induced liver injury inpatients in general hospital wards: A retrospective cohort study.
    Li D; Dong J; Xi X; Huang G; Li W; Chen C; Liu J; Du Q; Liu S
    Front Pharmacol; 2022; 13():972800. PubMed ID: 36110542
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drug-Induced Liver Injury (DILI) With Micafungin: The Importance of Causality Assessment.
    Mullins C; Beaulac K; Sylvia L
    Ann Pharmacother; 2020 Jun; 54(6):526-532. PubMed ID: 31786964
    [No Abstract]   [Full Text] [Related]  

  • 34. Utility of a Computerized ICD-10 Algorithm to Identify Idiosyncratic Drug-Induced Liver Injury Cases in the Electronic Medical Record.
    Yeboah-Korang A; Louissaint J; Tsung I; Prabhu S; Fontana RJ
    Drug Saf; 2020 Apr; 43(4):371-377. PubMed ID: 31916081
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exploring the efficacy and safety of polyene phosphatidylcholine for treatment of drug-induced liver injury using the Roussel Uclaf causality assessment method: a propensity score matching comparison.
    Lei X; Zhang J; Xu Q; Li J; Qian Y; Zhang J; Liu L; Zhong W; Wang Y; Han X; Tang J; Zeng M; Mao Y
    J Int Med Res; 2021 Aug; 49(8):3000605211039810. PubMed ID: 34433332
    [No Abstract]   [Full Text] [Related]  

  • 36. The Indian Network of Drug-Induced Liver Injury: Etiology, Clinical Features, Outcome and Prognostic Markers in 1288 Patients.
    Devarbhavi H; Joseph T; Sunil Kumar N; Rathi C; Thomas V; Prasad Singh S; Sawant P; Goel A; Eapen CE; Rai P; Arora A; Leelakrishnan V; Gopalakrishnan G; Vardhan Reddy V; Singh R; Goswami B; Venkataraman J; Balaraju G; Patil M; Patel R; Taneja S; Koshy A; Nagaraja Rao P; Kumar Sarin S; Rathi P; Dhiman R; Duseja AK; Vargese J; Kumar Jain A; Wadhawan M; Ranjan P; Karanth D; Ganesh P; Nijhawan S; Krishna Dhali G; Adarsh CK; Jhaveri A; Nagral A; Rao P; Shalimar
    J Clin Exp Hepatol; 2021; 11(3):288-298. PubMed ID: 33994711
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A prospective nationwide study of drug-induced liver injury in Korea.
    Suk KT; Kim DJ; Kim CH; Park SH; Yoon JH; Kim YS; Baik GH; Kim JB; Kweon YO; Kim BI; Kim SH; Kim IH; Kim JH; Nam SW; Paik YH; Suh JI; Sohn JH; Ahn BM; Um SH; Lee HJ; Cho M; Jang MK; Choi SK; Hwang SG; Sung HT; Choi JY; Han KH
    Am J Gastroenterol; 2012 Sep; 107(9):1380-7. PubMed ID: 22733303
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Traditional Chinese Medicine and Herb-induced Liver Injury: Comparison with Drug-induced Liver Injury.
    Jing J; Teschke R
    J Clin Transl Hepatol; 2018 Mar; 6(1):57-68. PubMed ID: 29577033
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Incidence, characteristics and risk factors for drug-induced liver injury in hospitalized patients: A matched case-control study.
    Kong X; Guo D; Liu S; Zhu Y; Yu C
    Br J Clin Pharmacol; 2021 Nov; 87(11):4304-4312. PubMed ID: 33948989
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Memantine-Induced Liver Injury With Probable Causality as Assessed Using the Roussel Uclaf Causality Assessment Method (RUCAM).
    Shumar J; Ordway S; Junga Z; Sadowski B; Torres D
    ACG Case Rep J; 2019 Aug; 6(8):e00184. PubMed ID: 31737715
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.